Rushikesh Sable Selected Research

compound 18

2/2018	Design of cyclic and d-amino acids containing peptidomimetics for inhibition of protein-protein interactions of HER2-HER3.
9/2017	A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rushikesh Sable Research Topics

Disease

4	Neoplasms (Cancer) 12/2020 - 01/2017
3	Rheumatoid Arthritis 01/2018 - 11/2015
3	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 11/2015
2	Lung Neoplasms (Lung Cancer) 02/2018 - 09/2017
1	Breast Neoplasms (Breast Cancer) 09/2017
1	Experimental Arthritis 11/2015

Drug/Important Bio-Agent (IBA)

4	PeptidomimeticsIBA 02/2018 - 11/2015
2	compound 18IBA 02/2018 - 09/2017
2	Peptides (Polypeptides)IBA 01/2018 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 11/2015
1	Amino Acids FDA Link 02/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	AnthracyclinesIBA 01/2017
1	Immunomodulating AgentsIBA 01/2016

Therapy/Procedure

2	Therapeutics 12/2020 - 09/2017
1	Immunomodulation 11/2015